Proteomic analysis of scleroderma lesional skin reveals activated wound healing phenotype of epidermal cell layer

Rheumatology

Volumn 47, Issue 12, 2008, Pages 1754-1760

  Aden, N ^a   Shiwen, X ^a   Aden, D ^a   Black, C ^a   Nuttall, A ^a   Denton, C P ^a   Leask, A ^a   Abraham, D ^a   Stratton, R ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Epidermis; Proteomics; Scleroderma; Wound healing

Indexed keywords

ALPHA 1 ANTITRYPSIN; CALRETICULIN; CARBONATE DEHYDRATASE; CARBONYL REDUCTASE; CASPASE 14; CATHEPSIN D; COLLAGEN TYPE 6; COLLAGEN TYPE 6 ALPHA 2; COLLAGEN TYPE 6 ALPHA 3; CYCLOPHILIN A; CYTOKERATIN 1; CYTOKERATIN 14; CYTOKERATIN 16; CYTOKERATIN 5; CYTOKERATIN 6; FRUCTOSE BISPHOSPHATE ALDOLASE; GALECTIN 7; HEAT SHOCK PROTEIN 27; LIPOCORTIN 2; PEROXIREDOXIN; SCLEROPROTEIN; SERUM AMYLOID P; TROPOMYOSIN; UNCLASSIFIED DRUG; VIMENTIN;

AMINO ACID SEQUENCE; ARTICLE; CELL DIFFERENTIATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENERGY METABOLISM; EPIDERMIS CELL; EXTRACELLULAR MATRIX; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MASS SPECTROMETRY; MYOFIBROBLAST; OXIDATIVE STRESS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEOMICS; SCLERODERMA; SKIN BIOPSY; TISSUE SPECIFICITY; TWO DIMENSIONAL GEL ELECTROPHORESIS; WOUND HEALING;

BIOPSY; CELL DIFFERENTIATION; EPIDERMIS; HUMANS; ISOELECTRIC FOCUSING; PHENOTYPE; PROTEINS; PROTEOMICS; SCLERODERMA, SYSTEMIC; SKIN; WOUND HEALING;

EID: 56649111439     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/ken370     Document Type: Article

References (49)

1. Varga J, Abraham D. Systemic sclerosis. A prototypic multisystem fibrotic disorder. J Clin Invest 2007;117:557-67.
2. Steen VD, Medsger TA Jr. Changes in causes of death in systemic sclerosis, 1972-2002. Ann Rheum Dis 2007;66:940-4.
3. Jimenez SA, Hitraya E, Varga J. Pathogenesis of scleroderma. Collagen. Rheum Dis Clin North Am 1996;22:647-74.
4. Baroni SS, Santillo M, Bevilacqua F et al. Stimulatory autoantibodies to the PDGF receptor in systemic sclerosis. N Engl J Med 2006;354:2667-76.
5. Pearson JD. The endothelium: Its role in scleroderma. Ann Rheum Dis 1991; 50(Suppl. 4):866-71.
6. Whitfield ML, Finlay DR, Murray JI et al. Systemic and cell type-specific gene expression patterns in scleroderma skin. Proc Natl Acad Sci USA 2003; 100:12319-24.
7. Smith EA, LeRoy EC. A possible role for transforming growth factor-beta in systemic sclerosis. J Invest Dermatol 1990;95:125S-7S.
8. Shi-Wen X, Chen Y, Denton CP et al. Endothelin-1 promotes myofibroblast induction through the ETa receptor via a rac/ phosphoinositide 3-kinase/Akt-dependent pathway and is essential for the enhanced contractile phenotype of fibrotic fibroblasts. Mol Biol Cell 2004;15:2707-19.
9. Dziadzio M, Usinger W, Leask A et al. N-terminal connective tissue growth factor is a marker of the fibrotic phenotype in scleroderma. Q J Med 2005;98:485-92.
10. Sun TT, Shih C, Green H. Keratin cytoskeletons in epithelial cells of internal organs. Proc Natl Acad Sci USA 1979;76:2813-7.
11. Freedberg IM, Tomic-Canic M, Komine M, Blumenberg M. Keratins and the keratinocyte activation cycle. J Invest Dermatol 2001;116:633-40.
12. Eckert RL, Rorke EA. Molecular biology of keratinocyte differentiation. Environ Health Perspect 1989;80:109-16.
13. Rao KS, Babu KK, Gupta PD. Keratins and skin disorders. Cell Biol Intern 1996;20:261-74.
14. Coulombe PA. Towards a molecular definition of keratinocyte activation after acute injury to stratified epithelia. Biochem Biophys Res Commun 1997;236:231-8.
15. Stoler A, Kopan R, Duvic M, Fuchs E. Use of monospecific antisera and cRNA probes to localize the major changes in keratin expression during normal and abnormal epidermal differentiation. J Cell Biol 1988;107:427-46.
16. Uchi H, Terao H, Koga T, Furue M. Cytokines and chemokines in the epidermis. J Dermatol Sci 2000;24(Suppl. 1):S29-38.
17. Gröne A. Keratinocytes and cytokines. Vet Immunol Immunopathol 2002;88:1-12.
18. Tabata H, Hara N, Otsuka S, Yamakage A, Yamazaki S, Koibuchi N. Correlation between diffuse pigmentation and keratinocyte-derived endothelin-1 in systemic sclerosis. Int J Dermatol 2000;39:899-902.
19. Rudnicka L, Varga J, Christiano AM, Iozzo RV, Jimenez SA, Uitto J. Elevated expression of type VII collagen in the skin of patients with systemic sclerosis regulation by transforming growth. J Clin Invest 1994;93:1709-15.
20. Distler O, Pap T, Kowal-Bielecka O et al. Overexpression of monocyte chemoattractant protein 1 in systemic sclerosis: Role of platelet-derived growth factor and effects on monocyte chemotaxis and collagen synthesis. Arthritis Rheum 2001;44:2665-78.
21. Davies CA, Jeziorska M, Freemont AJ, Herrick AL. The differential expression of VEGF, VEGFR-2, and GLUT-1 proteins in disease subtypes of systemic sclerosis. Hum Pathol 2006;37:190-7.
22. Distler JH, Jungel A, Kowal-Bielecka O et al. Expression of interleukin-21 receptor in epidermis from patients with systemic sclerosis. Arthritis Rheum 2005;52:856-64.
23. Subcommittee for scleroderma criteria of the American Rheumatism Association diagnostic, & therapeutic criteria committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980;23:581-90.
24. Yan JX, Harry RA, Spibey C, Dunn MJ. Postelectrophoretic staining of proteins separated by two-dimensional gel electrophoresis using SYPRO dyes. Electrophoresis 2000;21:3657-65.
25. Abraham DJ, Eckes B, Rajkumar V, Krieg T. New developments in fibroblast and myofibroblast biology: Implications for fibrosis and scleroderma. Curr Rheumatol Rep 2007;9:136-43.
26. Svegliati S, Cancello R, Sambo P et al. Platelet-derived growth factor and reactive oxygen species (ROS) regulate Ras protein levels in primary human fibroblasts via ERK1/2. Amplification of ROS and Ras in systemic sclerosis fibroblasts. J Biol Chem 2005;280:36474-82.
27. Levine JH, Moses HL, Gold LI, Nanney LB. Spatial and temporal patterns of immunoreactive transforming growth factor beta 1, beta 2, and beta 3 during excisional wound repair. Am J Pathol 1993;143:368-80.
28. Bauer BS, Tredget EE, Marcoux Y, Scott PG, Ghahary A. Latent and active transforming growth factor beta1 released from genetically modified keratinocytes modulates extracellular matrix expression by dermal fibroblasts in a coculture system. J Invest Dermatol 2002;119:456-63.
29. Selman M. Idiopathic pulmonary fibrosis challenges for the future. Chest 2001;120:8-10.
30. Selman M, Pardo A. Role of epithelial cells in idiopathic pulmonary fibrosis: From innocent targets to serial killers. Proc Am Thorac Soc 2006;4:364-72.
31. Funayama E, Chodon T, Oyama A, Sugihara T. Keratinocytes promote proliferation and inhibit apoptosis of the underlying fibroblasts: An important role in the pathogenesis of keloid. Invest Dermatol 2003;121:1326-31.
32. Bellemare J, Roberge CJ, Bergeron D, Lopez-Vallé CA, Roy M, Moulin VJ. Epidermis promotes dermal fibrosis: Role in the pathogenesis of hypertrophic scars. J Pathol 2005;206:1-8.
33. Rao KS, Babu KK, Gupta PD. Keratins and skin disorders. Cell Biol Int 1996;4:261-74.
34. Fuchs E, Green H. Changes in keratin gene expression during terminal differentiation of the keratinocyte. Cell 1980;19:1033-42.
35. Sonnenberg A, Calafat J, Janssen H et al. Integrin alpha 6/beta 4 complex is located in hemidesmosomes, suggesting a major role in epidermal cell-basement membrane adhesion. J Cell Biol 1991;113:907-17.
36. Kindås-Mügge I, Trautinger F. Increased expression of the M(r) 27,000 heat shock protein (hsp27) in in vitro differentiated normal human keratinocytes. Cell Growth Differ 1994;5:777-81.
37. Jonak C, Klosner G, Kokesch C, Fodinger D, Honigsmann H, Trautinger F. Subcorneal colocalization of the small heat shock protein, hsp27, with keratins and proteins of the cornified cell envelope. Br J Dermatol 2002;147:13-9.
38. Sauermann K, Gambichler T, Jaspers S et al. Histometric data obtained by in vivo confocal laser scanning microscopy in patients with systemic sclerosis. BMC Dermatol 2002;6:2-8.
39. Odland G, Ross R. Human wound repair. I. Epidermal regeneration. J Cell Biol 1968;1:135-51.
40. Varga J. Scleroderma and Smads: Dysfunctional Smad family dynamics culminating in fibrosis. Arthritis Rheum 2002;46:1703-13.
41. Singer AJ, Clark RA. Cutaneous wound healing. N Engl J Med 1999;341:738-46.
42. Raja, Sivamani K, Garcia MS, Isseroff RR. Wound re-epithelialization: modulating keratinocyte migration in wound healing. Front Biosci 2007;12:2849-68.
43. Grinnell F. Wound repair, keratinocyte activation and integrin modulation. J Cell Sci 1992;101:1-5.
44. Hertle MD, Kubler MD, Leigh IM, Watt FM. Aberrant integrin expression during epidermal wound healing and in psoriatic epidermis. J Clin Invest 1992; 89:1892-901.
45. Larjava H, Salo T, Haapasalmi K, Kramer RH, Heino J. Expression of integrins and basement membrane components by wound keratinocytes. J Clin Invest 1993; 92:1425-35.
46. Patel GK, Wilson CH, Harding KG, Finlay AY, Bowden PE. Numerous keratinocyte subtypes involved in wound re-epithelialization. J Invest Dermatol 2006; 126:497-502.
47. Paladini RD, Takahashi K, Bravo NS, Coulombe PA. Onset of re-epithelialization after skin injury correlates with a reorganization of keratin filaments in wound edge keratinocytes: Defining a potential role for keratin 16. J Cell Biol 1996;132:381-97.
48. Wong P, Coulombe PA. Loss of keratin 6 (K6) proteins reveals a function for intermediate filaments during wound repair. J Cell Biol 2003;163:327-37.
49. Laplante AF, Moulin V, Auger FA et al. Expression of heat shock proteins in mouse skin during wound healing. J Histochem Cytochem 1998;46:1291-301.